Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Study confirms link between PAP apnea treatment and dementia onset

Publish date:: September 16, 2020

Key clinical point: New data has confirmed a strong link between treatment for sleep apnea and a reduced risk of dementia.

Major finding: Obstructive sleep apnea (OSA) treatment was associated with a significantly lower odds of a diagnosis of Alzheimer’s disease (odds ratio 0.78; 95% confidence interval, 0.69-0.89).

Study details: With a random sample of Medicare beneficiaries and their claims data, investigators identified approximately 53,000 who had an OSA diagnosis prior to 2011.

Disclosures: Dr. Dunietz’s study was supported by The American Academy of Sleep Medicine Foundation. She reported having no disclosures. Dr. Varga said he has no relevant disclosures.

Citation:

Dunietz GL et al. Sleep 2020.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Sleep Medicine

Study links sleep meds and dementia risk in older adults,

Sleep apnea found to impact pain severity in younger adults,

OSA diagnoses not carried forward to the inpatient setting,

Study validates OSA phenotypes in Latinos,

Insomnia may have a role in generation of stressful life events,